Flavonoids acting on DNA topoisomerases: Recent advances and future perspectives in cancer therapy

P. Russo, A. Del Bufalo, A. Cesario

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Flavonoids, secondary metabolites ubiquitously produced in the plant kingdom, are low molecular weight polyphenolic molecules. They are characterized by variable chemical structures and show a vast array of biological activities (i.e.. antiviral, antiinflammatory, antitumor, antimicrobial, estrogenic, antiestrogenic, antioxidant, mutagenic and antimutagenic) targeting different pathways. Some of these compounds such as Genistein, Daidzein or its synthetic derivative Phenoxodiol as well as Luteolin and Quercetin are able to inhibit DNA topoisomerases. This review discusses that Flavonoids targeting DNA topoisomerases may lead to novel drug development with anticancer potential.

Original languageEnglish
Pages (from-to)5287-5293
Number of pages7
JournalCurrent Medicinal Chemistry
Volume19
Issue number31
DOIs
Publication statusPublished - Nov 2012

Fingerprint

DNA Topoisomerases
Flavonoids
Luteolin
Genistein
Quercetin
Metabolites
Bioactivity
Antiviral Agents
Neoplasms
Anti-Inflammatory Agents
Antioxidants
Molecular Weight
Molecular weight
Derivatives
Molecules
Therapeutics
Pharmaceutical Preparations

Keywords

  • Cell death
  • Clinical trials
  • DNA topoisomerases
  • DNA topoisomerases poisoning
  • Drug discovery and development
  • Flavonoids
  • Phenoxodiol
  • Systems Biology

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology

Cite this

Flavonoids acting on DNA topoisomerases : Recent advances and future perspectives in cancer therapy. / Russo, P.; Del Bufalo, A.; Cesario, A.

In: Current Medicinal Chemistry, Vol. 19, No. 31, 11.2012, p. 5287-5293.

Research output: Contribution to journalArticle

@article{3978404fd8724b2d93cfc8a9bf1310f2,
title = "Flavonoids acting on DNA topoisomerases: Recent advances and future perspectives in cancer therapy",
abstract = "Flavonoids, secondary metabolites ubiquitously produced in the plant kingdom, are low molecular weight polyphenolic molecules. They are characterized by variable chemical structures and show a vast array of biological activities (i.e.. antiviral, antiinflammatory, antitumor, antimicrobial, estrogenic, antiestrogenic, antioxidant, mutagenic and antimutagenic) targeting different pathways. Some of these compounds such as Genistein, Daidzein or its synthetic derivative Phenoxodiol as well as Luteolin and Quercetin are able to inhibit DNA topoisomerases. This review discusses that Flavonoids targeting DNA topoisomerases may lead to novel drug development with anticancer potential.",
keywords = "Cell death, Clinical trials, DNA topoisomerases, DNA topoisomerases poisoning, Drug discovery and development, Flavonoids, Phenoxodiol, Systems Biology",
author = "P. Russo and {Del Bufalo}, A. and A. Cesario",
year = "2012",
month = "11",
doi = "10.2174/092986712803833272",
language = "English",
volume = "19",
pages = "5287--5293",
journal = "Current Medicinal Chemistry",
issn = "0929-8673",
publisher = "Bentham Science Publishers B.V.",
number = "31",

}

TY - JOUR

T1 - Flavonoids acting on DNA topoisomerases

T2 - Recent advances and future perspectives in cancer therapy

AU - Russo, P.

AU - Del Bufalo, A.

AU - Cesario, A.

PY - 2012/11

Y1 - 2012/11

N2 - Flavonoids, secondary metabolites ubiquitously produced in the plant kingdom, are low molecular weight polyphenolic molecules. They are characterized by variable chemical structures and show a vast array of biological activities (i.e.. antiviral, antiinflammatory, antitumor, antimicrobial, estrogenic, antiestrogenic, antioxidant, mutagenic and antimutagenic) targeting different pathways. Some of these compounds such as Genistein, Daidzein or its synthetic derivative Phenoxodiol as well as Luteolin and Quercetin are able to inhibit DNA topoisomerases. This review discusses that Flavonoids targeting DNA topoisomerases may lead to novel drug development with anticancer potential.

AB - Flavonoids, secondary metabolites ubiquitously produced in the plant kingdom, are low molecular weight polyphenolic molecules. They are characterized by variable chemical structures and show a vast array of biological activities (i.e.. antiviral, antiinflammatory, antitumor, antimicrobial, estrogenic, antiestrogenic, antioxidant, mutagenic and antimutagenic) targeting different pathways. Some of these compounds such as Genistein, Daidzein or its synthetic derivative Phenoxodiol as well as Luteolin and Quercetin are able to inhibit DNA topoisomerases. This review discusses that Flavonoids targeting DNA topoisomerases may lead to novel drug development with anticancer potential.

KW - Cell death

KW - Clinical trials

KW - DNA topoisomerases

KW - DNA topoisomerases poisoning

KW - Drug discovery and development

KW - Flavonoids

KW - Phenoxodiol

KW - Systems Biology

UR - http://www.scopus.com/inward/record.url?scp=84870451613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870451613&partnerID=8YFLogxK

U2 - 10.2174/092986712803833272

DO - 10.2174/092986712803833272

M3 - Article

C2 - 22998568

AN - SCOPUS:84870451613

VL - 19

SP - 5287

EP - 5293

JO - Current Medicinal Chemistry

JF - Current Medicinal Chemistry

SN - 0929-8673

IS - 31

ER -